QGEN vs TECH
Qiagen N.V. vs Bio-Techne — AI-powered side-by-side comparison
| Metric | QGEN | TECH |
| AI Score |
71
|
71
|
| Price |
$42.98
|
$72.42
|
| P/E Ratio |
22.03×
|
61.88×
|
| ROE |
11.2%
|
8.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
61.8%
|
65.8%
|
| Debt / Equity |
0.49×
|
0.13×
|
| Dividend Yield |
6.1%
|
0.4%
|
| RSI (14) |
58.7
|
63.6
|
| Beta |
0.62
|
1.277
|
| Expected Upside |
+1.9%
|
—
|
AI Committee View
Current Innellis committee reasoning for QGEN versus TECH.
The committee scores are tied.
QGEN and TECH both score 71/100.
QGEN Committee View
75% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
TECH Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Weekly RSI at 75 -- overbought on the larger timeframe too — Technical